Navigation Links
Possibility Of Treatment For Permanent Hearing Loss

Researchers from University of Iowa and Okayama University, Japan, have reported a possible cure// for a kind of permanent hearing loss from parallel studies with animals.

The researchers gave a genetically deafened mouse interfering RNA that specifically prevents a gene from being expressed that would otherwise cause deafness. By preventing its expression, they had been able to prevent the deafness. Even at this early stage, the results are important feels the researchers because they point to other options for people who have hearing loss other than hearing aids or cochlear implants.

The gene-silencing technique used by the UI team is called RNA interference (RNAi) and works specifically against genetic conditions caused by a so-called dominant negative mechanism -- when a single copy of the mutant gene is sufficient to cause disease because the protein from the faulty gene has a dominant adverse effect over the protein from the normal gene. Several human forms of inherited deafness, including the one mimicked by the UI mouse model, are caused by a dominant negative mechanism.

To test the gene-silencing technique, the researchers had introduced a mutated gene that causes deafness in humans into the inner ear of mice. This gene acted through a dominant negative mechanism, and the mice had moderate hearing loss. Then they had simultaneously introduced the mutant gene and a short piece of interfering RNA specifically designed to silence the gene. Standard hearing tests, similar to those used on newborn babies, confirmed that the treated mice were able to hear.

The results said that RNA interference was not only successful but also highly specific. Despite the fact that the mouse and the human gene differed by only two nucleotides over the short stretch of gene targeted by the RNAi, the mutant human gene was silenced while the normal mouse gene was unaffected.

With a view to someday moving this therapy to humans
'"/>




Page: 1 2

Related medicine news :

1. Possibility of Link Diabetes with Iron
2. The Possibility Of Fighting HIV with Another Virus Questioned
3. New Hair in 15 Days Could Now Be A Possibility Say Researchers
4. Possibility Of Regaining Speech After Tongue, Voice Box Removal
5. Mumbai Alert: Possibility Of An Epidemic Outbreak
6. Limb Regeneration In Humans: A Future Possibility
7. Controversy: Malaria Vaccine - Future Possibility Or Just A Dream?
8. Possibility Of Bird Flu Outbreak In South Africa Ruled Out
9. Possibility Of A Meningococcal Outbreak In NSW
10. Advances in Treatment of Cataracts
11. Recommendations for Treatment of Blood Pressue
Post Your Comments:
(Date:10/10/2008)... MONTVALE, N.J., Oct. 10 /PRNewswire-FirstCall...ounces that it has appointed William,(Bill) Federi...oard to five,members., Mr. Federici joined West P... Financial Officer in August of 2003. Under his fi... have grown to more than $1.0 billion from,$300 mi...
(Date:10/10/2008)... RICHMOND, Va., Oct. 10 /PRNewswire/ -- Do you...ook? Can,t get around town? Attend the October,17 ...or the Blind and,Vision Impaired, and see how inst...red to lead productive, fulfilling lives through n...enter, located at 401 Azalea Avenue, is holding an...
(Date:10/10/2008)..., Upon the completion of ...BS Division of CDM Media proudly announces their n...or chief information technology executives in heal... Summit will launch May 10-12, 2009 at the Four Se... Honolulu, HI (PRWEB) October 11, 2008 -- ...
(Date:10/10/2008)..., DANVILLE, PA The American Nurses Credentialing...nter (GMC) as a Magnet hospital. The news came via...ses and staff who broke out with cheers and applau...ania hospitals and only 294 hospitals in the Unit...han 6,000 hospitals are eligible for this recognit...
Breaking Medicine News(10 mins):Health News:Synvista Therapeutics Appoints William Federici to its Board of Directors 2Health News:Synvista Therapeutics Appoints William Federici to its Board of Directors 3Health News:Virginia Rehabilitation Center for the Blind and Vision Impaired Celebrates Opening of New Student Dormitory 2Health News:CIO Healthcare Summit Announces Dates and VIP Delegates 2Health News:Geisinger Medical Center earns prestigious Magnet designation 2
...gh fungus-fighter drug - Noxafil, //which gained F... protecting patients with crippled immune systems,... The results of their study were published in the...art from preventing fungal infections, Noxafil, kn...
... has called for an action plan and comprehensive s... at a National Workshop// on ‘Human - Leopard Conf...eena, said that we need to have a re-look at our e...an-animal conflict is one of the challenging issue...
...patients for publishing their views on hospitals a... performance of their GPs or hospitals through pat...helping others to decide where to go for treatment...id that the aim is to improve the performance of t...
..., the University of Chicago, and Stanford, have st...essure earlier and// being more aggressive, physic...nificantly better than their counterparts. Their...Jan. 22, 2007, issue of the Archives of Internal M...
Other Medicine News:Health News:Hypertension Treatment: US Beats Europe 2Health News:Hypertension Treatment: US Beats Europe 3
(Date:10/9/2008)...ht Day 2008 focuses on the need to protect the eye...re/ -- Of the 45 million people worldwide who,are ...ers of them could,have avoided their blindness if ...view the Multimedia News Release, go to:, http://w...orld,s leader in eye care products and equipment, ...
(Date:10/8/2008)...A, Va., Oct. 8 /PRNewswire-USNewswire/ -- The fact... die from HIV/AIDS in,sub-Saharan Africa. More tha...an Africa have already died of AIDS. The Foundatio... ensure the dying and their families,find compassi...HSSA,s,innovative partnering initiative links Afri...
(Date:10/8/2008)... University Food Scientists Expand Testing Using C... Assay, PORTLAND, Maine, Oct. 8 /- W...with the release of results from a new study,showi...monly consumed,fruits like apples, bananas, red gr...e Cellular Antioxidant Activity (CAA) assay. New r...
(Date:10/7/2008)..., Oct. 7 /- Prometheus Laboratories I...ounced findings from its,development of PROMETHEUS...for irritable bowel syndrome (IBS). The findings s... particular biomarkers in blood samples,between IB...e biomarkers,combined with a proprietary algorith...
Breaking Medicine Technology:ORBIS and Alcon Call Attention to the Aging Eye 2ORBIS and Alcon Call Attention to the Aging Eye 3In celebration of World Hospice and Palliative Care Day, FHSSA Announces Seven New Partnerships Between U.S. Organizations and African Hospices 2In celebration of World Hospice and Palliative Care Day, FHSSA Announces Seven New Partnerships Between U.S. Organizations and African Hospices 3In celebration of World Hospice and Palliative Care Day, FHSSA Announces Seven New Partnerships Between U.S. Organizations and African Hospices 4Wild Blueberries Take Top Spot in New Antioxidant Research Study 2Wild Blueberries Take Top Spot in New Antioxidant Research Study 3Prometheus Presents Findings From Development of PROMETHEUS(R) IBS Diagnostic, First Blood Test for IBS, at ACG Annual Scientific Meeting 2Prometheus Presents Findings From Development of PROMETHEUS(R) IBS Diagnostic, First Blood Test for IBS, at ACG Annual Scientific Meeting 3Specialists in drug discovery and development convene 13455 1Specialists in drug discovery and development convene 13455 2Independence Blue Cross and The Childrens Hospital of Philadelphia Reach Seven Year Agreement 13453 1Independence Blue Cross and The Childrens Hospital of Philadelphia Reach Seven Year Agreement 13453 2Independence Blue Cross and The Childrens Hospital of Philadelphia Reach Seven Year Agreement 13453 3Achieving CVIS Goals Webinar 13451 1Achieving CVIS Goals Webinar 13451 2Autism Society of America Hosts Day on the Hill 13449 1Autism Society of America Hosts Day on the Hill 13449 2
...SYDNEY, Australia--(BUSINESS WIRE)--Jun 27, 2007 -...elltherapeutics.com) today,announced that it provi...a clinical trial to assess the safety, feasibility... stem cells into,spinal cord injury (SCI) patients... at the 13th,Annual Meeting of the International S...
...Final Results from Exploratory Phase IIa Clinical ...TO, June 28, 2007 /PRNewswire-FirstCall/ - Transit...nces the results from,its exploratory Phase IIa cl...tments with gastrin-based therapy, E1-I.N.T.(TM), ...ol parameters, including,haemoglobinA1C (HbA1c), f...
Other Medicine Technology:Clinical Trial Suggests Bone Marrow Stem Cells Are Useful for,Spinal Cord Injury; PrimeCell Therapeutics Provided Pre-Clinical,Study 2A 4-Week Therapy with Transition Therapeutics' E1-I.N.T. Leads to,Sustained Reductions in Blood Glucose Levels for 6 Months,Post-treatment in Type 2 Diabetes Patients 2A 4-Week Therapy with Transition Therapeutics' E1-I.N.T. Leads to,Sustained Reductions in Blood Glucose Levels for 6 Months,Post-treatment in Type 2 Diabetes Patients 3A 4-Week Therapy with Transition Therapeutics' E1-I.N.T. Leads to,Sustained Reductions in Blood Glucose Levels for 6 Months,Post-treatment in Type 2 Diabetes Patients 4A 4-Week Therapy with Transition Therapeutics' E1-I.N.T. Leads to,Sustained Reductions in Blood Glucose Levels for 6 Months,Post-treatment in Type 2 Diabetes Patients 5